Published in Cell Death Differ on September 02, 2011
The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res (2014) 1.16
Reprogramming of the microRNA transcriptome mediates resistance to rapamycin. J Biol Chem (2013) 1.06
Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1/206 microRNAs in differentiating myoblasts. J Biol Chem (2012) 1.01
Regulation of microRNA biogenesis and turnover by animals and their viruses. Cell Mol Life Sci (2013) 0.95
Therapeutic Opportunities for Targeting microRNAs in Cancer. Mol Cell Ther (2014) 0.94
MicroRNAs regulate and provide robustness to the myogenic transcriptional network. Curr Opin Pharmacol (2012) 0.93
Noncanonical G recognition mediates KSRP regulation of let-7 biogenesis. Nat Struct Mol Biol (2012) 0.92
RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathways. Front Immunol (2012) 0.89
H19 long noncoding RNA controls the mRNA decay promoting function of KSRP. Proc Natl Acad Sci U S A (2014) 0.89
Interleukin-10 inhibits lipopolysaccharide induced miR-155 precursor stability and maturation. PLoS One (2013) 0.88
Regulation of miRNA biogenesis as an integrated component of growth factor signaling. Curr Opin Cell Biol (2013) 0.88
Dysregulation of microRNA biogenesis machinery in cancer. Crit Rev Biochem Mol Biol (2015) 0.86
KSRP and MicroRNA 145 are negative regulators of lipolysis in white adipose tissue. Mol Cell Biol (2014) 0.86
PreImplantation factor promotes neuroprotection by targeting microRNA let-7. Proc Natl Acad Sci U S A (2014) 0.84
Signaling pathways that control mRNA turnover. Cell Signal (2013) 0.84
The many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities. Nucleic Acids Res (2015) 0.83
KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression. Diabetes (2014) 0.83
Converging pathways involving microRNA-206 and the RNA-binding protein KSRP control post-transcriptionally utrophin A expression in skeletal muscle. Nucleic Acids Res (2013) 0.81
Role of KSRP in control of type I interferon and cytokine expression. J Interferon Cytokine Res (2014) 0.80
KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression. J Lipid Res (2014) 0.79
HnRNP A1 tethers KSRP to an exon splicing silencer that inhibits an erythroid-specific splicing event in PU.1-induced erythroleukemia. Am J Cancer Res (2015) 0.79
Bit-1 is an essential regulator of myogenic differentiation. J Cell Sci (2015) 0.76
Myoprotective effects of bFGF on skeletal muscle injury in pressure-related deep tissue injury in rats. Burns Trauma (2016) 0.75
A cardiac myocyte-restricted Lin28/let-7 regulatory axis promotes hypoxia-mediated apoptosis by inducing the AKT signaling suppressor PIK3IP1. Biochim Biophys Acta (2015) 0.75
Diverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and disease. Wiley Interdiscip Rev RNA (2015) 0.75
KSRP promotes post-transcriptional destabilization of Spry4 transcripts in non-small cell lung cancer. J Biol Chem (2017) 0.75
Upregulation of KSRP by miR-27b provides IFN-γ-induced post-transcriptional regulation of CX3CL1 in liver epithelial cells. Sci Rep (2015) 0.75
Differentiation capacities of skeletal muscle satellite cells in Lantang and Landrace piglets. Oncotarget (2017) 0.75
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet (2005) 17.07
The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet (2010) 15.87
Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet (2007) 15.46
Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem (2010) 12.06
Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev (2006) 11.04
Cellular and molecular regulation of muscle regeneration. Physiol Rev (2004) 10.72
Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A (2006) 6.19
Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol (2006) 5.78
The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature (2009) 4.61
Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr Opin Cell Biol (1996) 4.60
Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell (2009) 3.90
Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest (2010) 3.09
MicroRNA control of muscle development and disease. Curr Opin Cell Biol (2009) 3.04
MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab (2010) 2.99
Essential role for Dicer during skeletal muscle development. Dev Biol (2007) 2.76
A new mutational AKTivation in the PI3K pathway. Cancer Cell (2007) 2.62
MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res (2006) 2.59
The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol Cell (2011) 2.50
Retracted The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol (2006) 2.42
p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell (2005) 2.38
MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal (2009) 2.38
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest (2009) 2.36
Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat Struct Mol Biol (2010) 2.30
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle (2011) 2.10
Emerging paradigms of regulated microRNA processing. Genes Dev (2010) 2.06
LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. FASEB J (2009) 1.99
Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol Cell Biol (2003) 1.93
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation (2009) 1.92
MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Struct Funct (2008) 1.76
Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell (2007) 1.70
Skeletal muscle stem cells in developmental versus regenerative myogenesis. J Intern Med (2009) 1.53
RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation. J Biol Chem (2003) 1.51
Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration. Trends Cell Biol (2009) 1.49
MicroRNAs in skeletal muscle: their role and regulation in development, disease and function. J Physiol (2010) 1.33
Posttranscriptional control of type I interferon genes by KSRP in the innate immune response against viral infection. Mol Cell Biol (2011) 1.13
KSRP, many functions for a single protein. Front Biosci (Landmark Ed) (2011) 1.13
Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. J Cell Physiol (2009) 1.05
Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts. J Cell Physiol (2001) 1.05
How to control miRNA maturation? RNA Biol (2009) 1.01
AKT-ing via microRNA. Cell Cycle (2010) 0.97
Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death Differ (2009) 0.96
The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev (2000) 11.65
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (1996) 11.02
A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature (1997) 9.71
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature (1997) 8.38
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature (1998) 8.33
Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature (1986) 7.81
AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell (2001) 7.79
Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature (1982) 6.56
The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev (1988) 6.23
RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell (1991) 5.89
Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature (1989) 5.68
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (1983) 5.20
Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature (1990) 5.20
Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev (1999) 4.92
Complex transcriptional units: diversity in gene expression by alternative RNA processing. Annu Rev Biochem (1986) 4.73
Functional domains of the human glucocorticoid receptor. Cell (1986) 4.68
A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell (1988) 4.57
Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science (1998) 4.55
Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J Biol Chem (1987) 4.32
Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature (1982) 4.30
The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell (1991) 4.27
Regulation of neuronal traits by a novel transcriptional complex. Neuron (2001) 4.02
The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell (1988) 3.91
Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (1995) 3.90
Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev (1998) 3.79
Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature (1987) 3.75
Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc (2000) 3.59
Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol (1998) 3.51
Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell (2000) 3.47
Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature (1988) 3.42
Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimer. Cell (1989) 3.24
Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature (1996) 3.21
I-POU: a POU-domain protein that inhibits neuron-specific gene activation. Nature (1991) 3.15
Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science (2000) 3.14
Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation. Cell (1989) 3.12
Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol (1999) 3.11
ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol (1998) 3.06
Nuclear receptor coactivators. Curr Opin Cell Biol (1997) 2.96
The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci U S A (2000) 2.92
Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev (1999) 2.92
Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science (1990) 2.92
Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature (1993) 2.83
Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature (1996) 2.81
The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell (1990) 2.78
Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science (1985) 2.77
Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science (1984) 2.75
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. J Immunol (2000) 2.65
Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature (1998) 2.65
Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature (1999) 2.64
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A (1997) 2.63
Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta. Science (1992) 2.61
SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. Mol Cell (1998) 2.60
Splice commitment dictates neuron-specific alternative RNA processing in calcitonin/CGRP gene expression. Cell (1987) 2.58
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A (1998) 2.55
Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev (2000) 2.54
Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48
POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev (1997) 2.48
A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol (1996) 2.47
Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial. Aging Ment Health (2010) 2.46
Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature (1994) 2.43
Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J (2000) 2.41
Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev (1990) 2.41
Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol (1998) 2.38
Biosynthesis of lysosomal hydrolases: their synthesis in bound polysomes and the role of co- and post-translational processing in determining their subcellular distribution. J Cell Biol (1982) 2.37
A family of LIM domain-associated cofactors confer transcriptional synergism between LIM and Otx homeodomain proteins. Genes Dev (1997) 2.35
Calcitonin/calcitonin gene-related peptide transcription unit: tissue-specific expression involves selective use of alternative polyadenylation sites. Mol Cell Biol (1984) 2.35
Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science (1988) 2.34
Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms. Cell (1986) 2.31
Signal-specific co-activator domain requirements for Pit-1 activation. Nature (1998) 2.22
Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product. Nature (1986) 2.18
Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci U S A (2000) 2.17
The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem (1991) 2.15
Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord (2002) 2.14
Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. J Biol Chem (1990) 2.13
Molecular cloning of a brain-specific calcium/calmodulin-dependent protein kinase. Proc Natl Acad Sci U S A (1987) 2.13
A c-erb-A binding site in rat growth hormone gene mediates trans-activation by thyroid hormone. Nature (1987) 2.11
Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev (1993) 2.11
Pitx2 determines left-right asymmetry of internal organs in vertebrates. Nature (1998) 2.10
Differential use of CREB binding protein-coactivator complexes. Science (1998) 2.10
Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron (1993) 2.10
Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell (1988) 2.08
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med (1998) 2.08
Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc (1993) 2.02
Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev (1998) 2.02
Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem (1998) 2.02
Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev (1996) 2.02
Epidermal growth factor rapidly stimulates prolactin gene transcription. Nature (1982) 1.97
Alternative RNA processing: determining neuronal phenotype. Science (1984) 1.97
Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet (2000) 1.90
Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J Biol Chem (1993) 1.88
Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev (1999) 1.88
Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain. Cell (1988) 1.87
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J (1998) 1.86
POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter. Genes Dev (1991) 1.84
Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor. Nature (1989) 1.84
Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. Nature (1996) 1.84
Control of alternative pre-mRNA splicing by distributed pentameric repeats. Proc Natl Acad Sci U S A (1997) 1.82
Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature (1993) 1.80
Infectious and selectable retrovirus containing an inducible rat growth hormone minigene. Science (1984) 1.80
A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer. Proc Natl Acad Sci U S A (1996) 1.80